XML 53 R27.htm IDEA: XBRL DOCUMENT v3.24.1
Stockholders' Equity (Deficit) (Tables)
12 Months Ended
Dec. 31, 2023
Stockholders' Equity (Deficit)  
Schedule of Warrant Information

On December 31, 2023 and 2022, outstanding Common Stock warrants to purchase shares of Common Stock, all classified as equity financial instruments, are as follows:

December 31, 2023

December 31, 2022

    

Exercise Price

    

Expiration Date

1,183,491

$

5.60

October 16, 2023

993,139

993,139

$

2.87

February 11, 2025

7,717,661

7,717,661

$

2.87

March 27, 2025

1,867,912

1,867,912

$

3.25

January 26, 2026

4,285,935

4,285,935

$

3.25

March 16, 2026

1,807,396

1,807,396

$

5.00

February 8, 2027

2,692,604

2,692,604

$

5.00

March 30, 2027

1,200

1,200

$

1,680.00

None

19,365,847

20,549,338

 

  

  

Shares Reserved for Future Issuance

As of December 31, 2023 and 2022, the Company had reserved shares of its Common Stock for future issuance as follows:

    

December 31, 2023

 

December 31, 2022

Stock options outstanding

 

3,165,216

3,352,803

Unvested restricted stock units

200,000

30,000

Employee stock purchase plan

 

9,748

9,748

Shares available for future grants under the 2016 Plan

 

2,368,160

570,570

Warrants outstanding

 

19,365,847

20,549,338

Shares issuable upon the conversion of Convertible Loan

21,293,861

Total shares reserved

 

46,402,832

24,512,459

Schedule of Shares Reserved for Future Issuance

    

December 31, 2023

 

December 31, 2022

Stock options outstanding

 

3,165,216

3,352,803

Unvested restricted stock units

200,000

30,000

Employee stock purchase plan

 

9,748

9,748

Shares available for future grants under the 2016 Plan

 

2,368,160

570,570

Warrants outstanding

 

19,365,847

20,549,338

Shares issuable upon the conversion of Convertible Loan

21,293,861

Total shares reserved

 

46,402,832

24,512,459